	US 11,857,623 B2
	Pan-antiallergy vaccine
Sari Sabban, Jeddah (SA)
Assigned to King Abdulaziz University, Jeddah (SA)
Filed by King Abdulaziz University, Jeddah (SA)
Filed on Aug. 7, 2020, as Appl. No. 16/988,076.
Prior Publication US 2022/0040296 A1, Feb. 10, 2022
Int. Cl. A61K 39/395 (2006.01); A61K 39/00 (2006.01)

CPC A61K 39/395 (2013.01) [A61K 2039/544 (2013.01); A61K 2039/555 (2013.01)]

14 Claims

1. A protein construct, comprising:

a scaffold segment and a motif segment,

wherein the scaffold segment comprises a protein that is exogenous to immunoglobulin E (“IgE”) which has been modified by insertion of the motif segment into the scaffold segment,

wherein the scaffold segment comprises an extracellular adherence protein (EAP) IYN3 chain A (SEQ ID NO: 5), and

wherein the motif segment comprises an IgE FG loop (SEQ ID NO: 2) and

wherein the construct comprises any one of SEQ ID NOS: 7-16.